Cargando…
GSTP1 polymorphism predicts treatment outcome and toxicities for breast cancer
This study aimed to investigate the association of the GSTP1 gene polymorphism with the outcomes and toxicities of treatments in breast cancer. Odds ratios (ORs) and 95% confidence intervals (95% CIs) were calculated for the association of GSTP1 polymorphism with tumour response and toxicities, and...
Autores principales: | Ma, Jie, Zhu, Shao-Liang, Liu, Yang, Huang, Xiang-Yang, Su, Dan-Ke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641181/ https://www.ncbi.nlm.nih.gov/pubmed/29069838 http://dx.doi.org/10.18632/oncotarget.18513 |
Ejemplares similares
-
Association between MTHFR C677T Polymorphism and Risk of Acute Lymphoblastic Leukemia: A Meta-Analysis Based on 51 Case-Control Studies
por: Li, Su-yi, et al.
Publicado: (2015) -
Association of COL1A1 rs1800012 polymorphism with musculoskeletal degenerative diseases: a meta-analysis
por: Zhong, Binlong, et al.
Publicado: (2017) -
Association between BRCA1 polymorphisms rs799917 and rs1799966 and breast cancer risk: a meta-analysis
por: Yang, Meiming, et al.
Publicado: (2019) -
Chinese C allele carriers of the ERCC5 rs1047768 polymorphism are more sensitive to platinum-based chemotherapy: a meta-analysis
por: Xu, Meizhen, et al.
Publicado: (2017) -
The incidence and relative risk of adverse events in patients treated
with bisphosphonate therapy for breast cancer: a systematic review and
meta-analysis
por: Yang, Yan-Li, et al.
Publicado: (2019)